It is a pharma private limited company based in Delhi, Delhi, India, established in 2009.
2009 | Delhi, Delhi, India | ActiveDorris Pharmaceuticals Private Limited, a active private limited company, was established on 28 August 2009 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100DL2009PTC193644. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Priyanka (Director), Krishan Lal Mittal (Additional Director). Past directors included Vikas Krishan, Neelesh Tiwari, Krishan Lal Mittal. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 92, Ravi Dass Nagar Narela, Delhi, Delhi, 110040.
U24100DL2009PTC193644
193644
28 August 2009
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Dorris Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priyanka | Director | 08 Feb 2013 | Current |
| Krishan Lal Mittal | Additional Director | 20 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Feb 2013 | Past |
| Pramod Abcsdd | Director | 20 Jan 2016 | Past |
| Pramod Abcsdd | Director | 10 Jun 2019 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dorris Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 77.82% decrease. The company also saw a substantial fall in profitability, with a 60.68% decrease in profit. The company's net worth moved up by a moderate rise of 7.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Dorris Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Dorris Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dorris Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dorris Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Dorris Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Dorris Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity Krishan Lal Mittal was appointed as a Additional Director was appointed as a Additional Director on 20 Mar 2022 & has been associated with this company since 3 years 8 months . was completed.
The activity Priyanka was appointed as a Director was appointed as a Director on 08 Feb 2013 & has been associated with this company since 12 years 9 months . was completed.
Progress on Dorris Pharmaceuticals Private Limited was registered on 28 Aug 2009 with Roc Delhi & aged 16 years 3 months as per MCA records. was documented.
The CIN of Dorris Pharmaceuticals Private Limited is U24100DL2009PTC193644.
Dorris Pharmaceuticals Private Limited is headquartered at 92, Ravi Dass Nagar Narela, Delhi, Delhi, 110040.
Dorris Pharmaceuticals Private Limited was incorporated on 28 August 2009.
The current directors of Dorris Pharmaceuticals Private Limited are
The primary industry of Dorris Pharmaceuticals Private Limited is Trade.
Dorris Pharmaceuticals Private Limited is unlisted.
The authorized capital of Dorris Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Dorris Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX